Fisher & Paykel Healthcare's Progress Attracts New Bull -- Market Talk

Dow Jones

05/29

2226 GMT [Dow Jones]--Fisher & Paykel Healthcare gets a new bull in Jefferies following its FY 2025 result that showed growth across key divisions. Annual revenue rose by 16% on a year ago, with new app consumables up 20% and masks for treating sleep apnea up 14%. Gross margin expanded by 181 basis points. "With lead share, ongoing gains through clinical practice, further operating leverage and, as we see it, better placed with regard to tariffs, we move to Buy (from Hold)," says analyst Vanessa Thomson. Fisher & Paykel Healthcare is up 0.2% in early trading at NZ$35.07. (david.winning@wsj.com)

(END) Dow Jones Newswires

May 28, 2025 18:28 ET (22:28 GMT)

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2539111402"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2539111402\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2539111402?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-29 06:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2539111402","market":"hk","top_or_hot":-1,"title":"Fisher & Paykel Healthcare's Progress Attracts New Bull -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  2226 GMT [Dow Jones]--Fisher &amp; Paykel Healthcare gets a new bull in Jefferies following its FY 2025 result that showed growth across key divisions. Annual revenue rose by 16% on a year ago, with new app consumables up 20% and masks for treating sleep apnea up 14%. Gross margin expanded by 181 basis points. \"With lead share, ongoing gains through clinical practice, further operating leverage and, as we see it, better placed with regard to tariffs, we move to Buy (from Hold),\" says analyst Vanessa Thomson. Fisher &amp; Paykel Healthcare is up 0.2% in early trading at NZ$35.07. (david.winning@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 28, 2025 18:28 ET (22:28 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fisher & Paykel Healthcare's Progress Attracts New Bull -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFisher & Paykel Healthcare's Progress Attracts New Bull -- Market Talk\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-05-29 06:28</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  2226 GMT [Dow Jones]--Fisher &amp; Paykel Healthcare gets a new bull in Jefferies following its FY 2025 result that showed growth across key divisions. Annual revenue rose by 16% on a year ago, with new app consumables up 20% and masks for treating sleep apnea up 14%. Gross margin expanded by 181 basis points. \"With lead share, ongoing gains through clinical practice, further operating leverage and, as we see it, better placed with regard to tariffs, we move to Buy (from Hold),\" says analyst Vanessa Thomson. Fisher &amp; Paykel Healthcare is up 0.2% in early trading at NZ$35.07. (david.winning@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 28, 2025 18:28 ET (22:28 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FPH.NZ","symbol_name":"Fisher & Paykel Healthcare Corporation Limited Ord Shares","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2539111402","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2539111402","pubTimestamp":1748471280,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"2226 GMT [Dow Jones]--Fisher & Paykel Healthcare gets a new bull in Jefferies following its FY 2025 result that showed growth across key divisions. Annual revenue rose by 16% on a year ago, with new app consumables up 20% and masks for treating sleep apnea up 14%. Gross margin expanded by 181 basis points. \"With lead share, ongoing gains through clinical practice, further operating leverage and, as we see it, better placed with regard to tariffs, we move to Buy ,\" says analyst Vanessa Thomson. Fisher & Paykel Healthcare is up 0.2% in early trading at NZ$35.07. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"FPH.NZ":"Fisher & Paykel Healthcare Corporation Limited Ord Shares","HCSG":"Healthcare Svcs Group Inc","BK4097":"系统软件","PRGS":"Progress Software Corporation","BK8004":"医疗保健设备","LU2065732104.USD":"ALLSPRING (LUX) WF GLOBAL SMALL CAP EQUITY \"I\" (USD) ACC","BK4137":"综合支持服务"},"translate_title":"斐雪派克医疗保健的进展吸引了新的牛市讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PRGS":1,"HCSG":1,"FPH.NZ":1},"content_text":"2226 GMT [Dow Jones]--Fisher & Paykel Healthcare gets a new bull in Jefferies following its FY 2025 result that showed growth across key divisions. Annual revenue rose by 16% on a year ago, with new app consumables up 20% and masks for treating sleep apnea up 14%. Gross margin expanded by 181 basis points. \"With lead share, ongoing gains through clinical practice, further operating leverage and, as we see it, better placed with regard to tariffs, we move to Buy (from Hold),\" says analyst Vanessa Thomson. Fisher & Paykel Healthcare is up 0.2% in early trading at NZ$35.07. (david.winning@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 28, 2025 18:28 ET (22:28 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}